We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVAC
751
DELISTED
Riverview Acquisition Corp. Class A Common Stock
RVAC
$12M 0.02%
1,224,958
MDAI icon
752
Spectral AI
MDAI
$52.2M
$12M 0.02%
1,226,155
BPMC
753
DELISTED
Blueprint Medicines
BPMC
$11.9M 0.02%
186,600
-764,082
-80% -$54.8M
CCJ icon
754
Cameco
CCJ
$38.8B
$11.9M 0.02%
407,739
-17,154
-4% -$402K
HZON
755
DELISTED
Horizon Acquisition Corporation II
HZON
$11.9M 0.02%
1,196,595
+26,364
+2% +$259K
CHAA
756
DELISTED
Catcha Investment Corp
CHAA
$11.9M 0.02%
1,210,607
HPX
757
DELISTED
HPX Corp.
HPX
$11.8M 0.02%
1,194,226
MT icon
758
ArcelorMittal
MT
$50.7B
$11.8M 0.02%
+369,926
New +$11.9M
ASAQ
759
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
$11.8M 0.02%
1,197,484
GETR
760
DELISTED
Getaround, Inc.
GETR
$11.8M 0.02%
1,205,519
EVH icon
761
Evolent Health
EVH
$439M
$11.8M 0.02%
364,030
+134,134
+58% +$3.51M
SIX
762
DELISTED
Six Flags Entertainment Corp.
SIX
$11.7M 0.02%
269,200
-292,916
-52% -$12.3M
JCIC
763
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
$11.6M 0.02%
1,186,837
+100
+0% +$976
COLI
764
DELISTED
Colicity Inc. Class A Common Stock
COLI
$11.6M 0.02%
1,186,828
+4,505
+0.4% +$43.9K
GS icon
765
CALL
Goldman Sachs
GS
$308B
$11.6M 0.02%
+35,100
New +$12.4M
OUST icon
766
Ouster
OUST
$2.35B
$11.6M 0.02%
257,310
+220,109
+592% +$8.12M
APSG.WS
767
CALL
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$11.6M 0.02%
1,162,222
-160,000
-12% -$173K
CALM icon
768
Cal-Maine
CALM
$4.22B
$11.6M 0.02%
+209,211
New +$9.11M
FRXB
769
DELISTED
Forest Road Acquisition Corp. II
FRXB
$11.5M 0.02%
1,180,794
FBIN icon
770
Fortune Brands Innovations
FBIN
$6.11B
$11.5M 0.02%
181,671
+104,278
+135% +$8.02M
EXAI
771
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$11.5M 0.02%
800,917
-24,260
-3% -$413K
SBII
772
DELISTED
Sandbridge X2 Corp.
SBII
$11.5M 0.02%
1,182,344
YTPG
773
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$11.5M 0.02%
1,171,003
DLTR icon
774
Dollar Tree
DLTR
$23.8B
$11.4M 0.02%
71,411
-321,841
-82% -$45.5M
SOC icon
775
Sable Offshore Corp
SOC
$845M
$11.4M 0.02%
1,171,025
+6,460
+0.6% +$62.8K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.